TrialBritish journal of haematology2020

Long-term data from a phase 3 study of radotinib versus imatinib in patients with newly diagnosed, chronic myeloid leukaemia in the chronic phase (RERISE).

Young Rok Do et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.